Similar articles

• [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].

  Costantino S, Millozzi F, Scarlata S. Costantino S, et al. Clin Ter. 2001 Mar-Apr;152(2):77-8. Clin Ter. 2001. PMID: 11441526 Italian. No abstract available.
• [Management of hypertensive patients with cardiovascular damage].

  Tomiyama H, Takata Y, Yamashina A. Tomiyama H, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:612-6. Nihon Rinsho. 2004. PMID: 15171444 Review. Japanese. No abstract available.
• [Organ protection by angiotensin II receptor blockers].

  Kumagai H, Onami T, Takimoto C, Iigaya K, Saruta T. Kumagai H, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:569-73. Nihon Rinsho. 2004. PMID: 15171437 Review. Japanese. No abstract available.
• [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].

  Baumgart P. Baumgart P. MMW Fortschr Med. 2006 Mar 16;148(11):57, 59-60. MMW Fortschr Med. 2006. PMID: 16612965 German. No abstract available.
• Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.

  Dahlöf B. Dahlöf B. J Hum Hypertens. 1995 Nov;9 Suppl 5:S37-44. J Hum Hypertens. 1995. PMID: 8583480 Review.